10,290 research outputs found
Eternally accelerating spacelike braneworld cosmologies
We construct an eternally inflating spacelike brane world model. If the space
dimension of the brane is three (SM2) or six (SM5) for M theory or four (SD3)
for superstring theory, a time-dependent -form field would supply a constant
energy density and cause exponentially expansion of the spacelike brane. In
these cases, the hyperbolic space perpendicular to the brane would not vary in
size. In the other cases, however, the extra space would vary in size.Comment: 8 pages, Mod. Phys. Lett. A Vol.21, No.40(2006) 2989-299
Eternally inflating cosmologies from intersecting spacelike branes
Intersecting spacelike braneworld cosmologies are investigated. The time axis
is set on the scale parameter of extra space, which may include more than one
timelike metric. Obtained are eternally inflating (i.e. undergoing late-time
inflation) Robertson-Walker spacetime and extra space with a constant scale
factor. In the case of multibrane solutions, some dimensions are static or
shrink. The fact that the largest supersymmetry algebra contains 32
supercharges in 4 dimensions imposes a restriction on the geometry of extra
space.Comment: 19 page
EXAFS Study on Local Structure of Iron Crystal by the Use of Asymmetrical Monochromator and PSPC
The EXAFS spectroscopy equipment constructed from an asymmetrical cut flat monochromator and PSPC is applied to the structural determination of pure α-iron which has small difference (0.038nm) in the first and second nearest neighbour distance. The efficiency of the curve fitting method for the two shell model of known structure material (α-iron) is discussed, in addition to describing the details of the experimental procedure of our new type of spectrometer and of the EXAFS data analysis
An augmented moment method for stochastic ensembles with delayed couplings: II. FitzHugh-Nagumo model
Dynamics of FitzHugh-Nagumo (FN) neuron ensembles with time-delayed couplings
subject to white noises, has been studied by using both direct simulations and
a semi-analytical augmented moment method (AMM) which has been proposed in a
recent paper [H. Hasegawa, E-print: cond-mat/0311021]. For -unit FN neuron
ensembles, AMM transforms original -dimensional {\it stochastic} delay
differential equations (SDDEs) to infinite-dimensional {\it deterministic} DEs
for means and correlation functions of local and global variables.
Infinite-order recursive DEs are terminated at the finite level in the
level- AMM (AMM), yielding -dimensional deterministic DEs. When a
single spike is applied, the oscillation may be induced if parameters of
coupling strength, delay, noise intensity and/or ensemble size are appropriate.
Effects of these parameters on the emergence of the oscillation and on the
synchronization in FN neuron ensembles have been studied. The synchronization
shows the {\it fluctuation-induced} enhancement at the transition between
non-oscillating and oscillating states. Results calculated by AMM5 are in
fairly good agreement with those obtained by direct simulations.Comment: 15 pages, 3 figures; changed the title with correcting typos,
accepted in Phys. Rev. E with some change
Small bowel transplantation in sensitized recipients: Comparison with heart, kidney, and liver grafts
Plasmon transport in graphene investigated by time-resolved measurement
Plasmons, which are collective charge oscillations, offer the potential to
use optical signals in nano-scale electric circuits. Recently, plasmonics using
graphene have attracted interest, particularly because of the tunable plasmon
frequency through the carrier density . However, the dependence of the
plasmon velocity is weak () and it is difficult to tune the
frequency over orders of magnitude. Here, we demonstrate that the velocity of
plasmons in graphene can be changed over two orders of magnitude by applying a
magnetic field and by the presence/absence of a gate; at high , edge
magnetoplasmons (EMPs), which are plasmons localized at the sample edge, are
formed and their velocity depends on and the gate screening effect. The
wide range tunability of the velocity and the observed low-loss plasmon
transport encourage designing graphene nanostructures for plasmonics
applications.Comment: submitte
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs
Heterotopic hamster hearts transplanted to unmodified LEW rats underwent humoral rejection in 3 days. Survival was prolonged to a median of 4 days with 2 mg/kg/day FK506. As monotherapy, 15 mg/kg/day cyclophosphamide greatly prolonged graft survival-far more than could be accomplished with RS-61443, brequinar (BQR), mizoribine, methotrexate, or deoxyspergualin. However, when FK506 treatment, which was ineffective alone, was combined with a short induction course (14 or 30 days) of subtherapeutic BQR, RS-61443, or cyclophosphamide, routine survival of heart xenografts was possible for as long as the daily FK506 was continued. In addition, a single large dose of 80 mg/kg cyclophosphamide 10 days preoperatively allowed routine cardiac xenograft survival under FK506. The ability of these antimetabolites to unmask the therapeutic potential of FK506 correlated, although imperfectly, with the prevention of rises of preformed heterospecific cytotoxic antibodies immediately postoperatively. As an adjunct to FK506, azathioprine was of marginal value, whereas mizoribine, methotrexate, and deoxyspergualin (DSPG) were of intermediate efficacy. After orthotopic hepatic xenotransplantation, the perioperative survival of the liver with its well-known resistance to antibodies was less dependent than the heart on the antimetabolite component of the combined drug therapy, but the unsatisfactory results with monotherapy of FK506, BQR, RS-61443, or cyclophosphamide were changed to routine success by combining continuous FK506 with a short course of any of the other drugs. Thus, by breaking down the antibody barrier to xenotransplantation with these so-called antiproliferative drugs, it has been possible with FK506 to transplant heart and liver xenografts with consistent long-term survival of healthy recipients
- …
